Home
GNTA

GNTA

Genenta Science S.p.A.

as of 12-02-2025 4:00pm EST

$1.93

$0.09

-4.46%

Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Chart Type:

Time Range:

Founded:	2014	Country:	Italy
Employees:	N/A	City:	N/A
Market Cap:	39.4M	IPO Year:	2021
Target Price:	N/A	AVG Volume (30 days):	136.9K
Analyst Decision:	N/A	Number of Analysts:	N/A
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-0.55	EPS Growth:	N/A
52 Week Low/High:	$1.35 - $10.00	Next Earning Date:	01-01-0001
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

AI-Powered GNTA Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold

Model Accuracy: 65.85%

65.85%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full GNTA Forecast & Prediction with Hourly Data

Compare GNTA vs Leading Stocks

See how GNTA stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free GNTA Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "GNTA Genenta Science S.p.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.